AstraZeneca
AZN
AZN
1,136 hedge funds and large institutions have $33.7B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 486 increasing their positions, 339 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.46% less ownership
Funds ownership: 32.55% → 32.09% (-0.46%)
1% less capital invested
Capital invested by funds: $34B → $33.7B (-$245M)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
Holders
1,136
Holding in Top 10
12
Calls
$480M
Puts
$470M
Top Buyers
| 1 | +$610M | |
| 2 | +$502M | |
| 3 | +$172M | |
| 4 |
Millennium Management
New York
|
+$154M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$150M |
Top Sellers
| 1 | -$924M | |
| 2 | -$675M | |
| 3 | -$160M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$132M |
| 5 |
D.E. Shaw & Co
New York
|
-$105M |